Randall B. Brenner net worth and biography

Randall Brenner Biography and Net Worth

Randy Brenner has been Paratek’s Chief Development and Regulatory Officer since June 2019. Since 2015, Mr. Brenner has been part of the Executive team leading the regulatory, quality and manufacturing activities for NUZYRA’s development and approval.

Prior to Paratek, Mr. Brenner was the Global Head of Regulatory Affairs at Shire Pharmaceuticals where he was responsible for all aspects of regulatory for a broad range of programs in multiple therapeutic areas and pharmaceutical technologies. Before that, Mr. Brenner was Head of Regulatory Affairs for the Emerging Markets and Established Products Business Units at Pfizer. In this role, he played an active part on the regional leadership teams and was responsible for the regulatory activities and staff leading the development, registration, launch, and life cycle of all of Pfizer's innovative products outside the United States and European Union as well as the Established Products business in all regions.

Prior to Pfizer, Mr. Brenner spent 14 years at Wyeth Pharmaceuticals, where he held multiple senior regulatory positions.

‍Education and Accomplishments
‍Mr. Brenner has a B.S. in Chemistry from Muhlenberg College and an M.S. in Pharmaceutical Sciences from Temple University.

What is Randall B. Brenner's net worth?: The estimated net worth of Randall B. Brenner is at least $925,916.07 as of August 9th, 2023. Mr. Brenner owns 415,209 shares of Paratek Pharmaceuticals stock worth more than $925,916 as of April 24th. This net worth estimate does not reflect any other assets that Mr. Brenner may own. Learn More about Randall B. Brenner's net worth.
How old is Randall B. Brenner?: Mr. Brenner is currently 50 years old. There are 5 older executives and no younger executives at Paratek Pharmaceuticals. The oldest executive at Paratek Pharmaceuticals is Mr. Michael F. Bigham CPA, CPA, M.B.A., MBA, Exec. Chairman, who is 65 years old. Learn More on Randall B. Brenner's age.
How do I contact Randall B. Brenner?: The corporate mailing address for Mr. Brenner and other Paratek Pharmaceuticals executives is 75 PARK PLAZA, BOSTON MA, 02116. Paratek Pharmaceuticals can also be reached via phone at (617) 807-6600 and via email at [email protected]. Learn More on Randall B. Brenner's contact information.
Has Randall B. Brenner been buying or selling shares of Paratek Pharmaceuticals?: Randall B. Brenner has not been actively trading shares of Paratek Pharmaceuticals during the last quarter. Most recently, Randall B. Brenner sold 27,603 shares of the business's stock in a transaction on Wednesday, August 9th. The shares were sold at an average price of $2.20, for a transaction totalling $60,726.60. Following the completion of the sale, the insider now directly owns 415,209 shares of the company's stock, valued at $913,459.80. Learn More on Randall B. Brenner's trading history.
Who are Paratek Pharmaceuticals' active insiders?: Paratek Pharmaceuticals' insider roster includes Michael Bigham (Chairman), Randall Brenner (Insider), William Haskel (General Counsel), Evan Loh (CEO), and Adam Woodrow (Insider). Learn More on Paratek Pharmaceuticals' active insiders.
Are insiders buying or selling shares of Paratek Pharmaceuticals?: During the last year, insiders at the specialty pharmaceutical company sold shares 4 times. They sold a total of 142,346 shares worth more than $313,161.20. The most recent insider tranaction occured on August, 9th when insider Randall B Brenner sold 27,603 shares worth more than $60,726.60. Insiders at Paratek Pharmaceuticals own 8.0% of the company. Learn More about insider trades at Paratek Pharmaceuticals.
Information on this page was last updated on 8/9/2023.

Randall B. Brenner Insider Trading History at Paratek Pharmaceuticals

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/9/2023	Sell	27,603	$2.20	$60,726.60	415,209
8/9/2022	Sell	19,608	$2.66	$52,157.28	349,149
12/15/2021	Sell	15,780	$4.27	$67,380.60
12/13/2021	Sell	4,479	$4.42	$19,797.18
8/17/2021	Sell	8,766	$5.12	$44,881.92	512,296
11/13/2020	Sell	8,357	$5.93	$49,557.01	152,063
5/12/2020	Sell	6,198	$4.75	$29,440.50	130,813
12/12/2019	Sell	6,278	$3.10	$19,461.80	92,011
10/3/2019	Sell	7,674	$3.98	$30,542.52	91,338

Randall B. Brenner Buying and Selling Activity at Paratek Pharmaceuticals

Paratek Pharmaceuticals Company Overview

Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its products include NUZYRA, a once-daily oral and intravenous broad-spectrum antibiotic for the treatment of adult patients with community-acquired bacterial pneumonia, and acute skin and skin structure infections caused by susceptible pathogens; and SEYSARA, a once-daily oral therapy for the treatment of moderate to severe acne vulgaris. The company has license and collaboration agreements with Zai Lab (Shanghai) Co., Ltd. and Allergan plc; license agreement with Tufts University to develop and commercialize products for the treatment or prevention of bacterial or microbial diseases, or medical conditions; and contract with Biomedical Advanced Research and Development Authority to support the development of NUZYRA for the treatment of pulmonary anthrax. It also has license agreement with Tetraphase Pharmaceuticals, Inc. to develop, import, and sell the XERAVATM product, which is used for the treatment of complicated intra-abdominal infections caused by bacteria. The company was founded in 1996 and is headquartered in Boston, Massachusetts.

Today's Range

Now: $2.23

$2.19

$2.24

50 Day Range

MA: $2.22

$2.17

$2.23

2 Week Range

Now: $2.23

$1.29

$3.65

Volume

4,764,400 shs

Average Volume

724,253 shs

Market Capitalization

$127.82 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.7

Exposed: 10 CENT Crypto to Explode April 20th?

From True Market Insiders | Ad

Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin

Click For My #1 FREE Crypto for 2024

Randall Brenner Biography and Net Worth

What is Randall B. Brenner's net worth?

How old is Randall B. Brenner?

How do I contact Randall B. Brenner?

Has Randall B. Brenner been buying or selling shares of Paratek Pharmaceuticals?

Who are Paratek Pharmaceuticals' active insiders?

Are insiders buying or selling shares of Paratek Pharmaceuticals?